View Clinical Trial (Medical Research Study)
An Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon In Patients With Alzheimer's Disease - NCT00939783-54601(Clinical Trial 350988)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
La Crosse |
|
State:
|
|
WI |
| Zip Code: |
|
54601 |
| Conditions: |
|
Alzheimer's Disease |
| Purpose: |
|
The purpose of this study is to evaluate the long-term safety and tolerability of Dimebon in
patients with Alzheimer's disease.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Completion of previous Phase 3 Dimebon study (B1451027).
Exclusion Criteria:
- Have any severe acute or chronic medical or psychiatric condition or laboratory
abnormality that may increase the risk associated with study participation or
investigational product administration or may interfere with the interpretation of
study results and, in the judgment of the investigator, would make the patient
inappropriate for entry into this study. |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
June 7, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|